查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589156

冠狀動脈繞道手術移植物市場：按方法、技術和產品分類 - 2025-2030 年全球預測

Coronary Artery Bypass Grafts Market by Method (Minimally Invasive Direct CABG, Off-Pump, On-Pump), Procedure (Double CABG Surgery, Quadruple CABG Surgery, Single CABG Surgery), Product - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年冠狀動脈繞道手術移植物市場價值為171.1億美元，預計到2024年將達到181.6億美元，複合年成長率為6.19%，到2030年將達到260.5億美元。

冠狀動脈繞道手術手術（CABG）市場涉及透過將血液引導至阻塞或患病動脈來改善心臟血流量的外科手術。對 CABG 的需求源自於其在治療冠狀動脈疾病 (CAD) 中的重要作用，而冠狀動脈疾病是全球死亡的主要原因。 CABG 主要用於醫院和心臟中心，在這些中心進行複雜的手術以改善患者的預後。最終用途範圍廣泛，可解決急診和擇期手術中的急性冠狀動脈症狀。 CABG 市場的關鍵成長要素包括由於人口老化和生活方式相關風​​險因素導致 CAD 盛行率增加、手術技術的進步以及合成和組織工程選擇等移植材料的創新。對微創手術不斷成長的需求代表著一個潛在的機會，因為它可以縮短康復時間並改善患者體驗。策略建議包括投資研發以開發新型植入材料和技術、擴展到新興市場以及與醫療保健提供者建立夥伴關係以更好地推廣。然而，該市場面臨可能影響其成長軌蹟的限制，包括高昂的手術成本、監管挑戰以及血管成形術和置入術等替代療法的可用性。為了應對這些挑戰，需要專注於降低成本策略並改善病患教育，以強調 CABG 的益處。需要創新的領域包括開發更耐用和生物相容的移植材料以及機器人輔助手術的進步。此外，可以利用巨量資料和人工智慧透過客製化治療和預測併發症來改善患者的治療結果。市場仍然充滿競爭，無論是老牌企業還是專注於技術突破的新進者。為了取得成功，公司必須專注於技術進步、成本效率和策略聯盟，以應對不斷變化的情況。

主要市場統計
基準年[2023] 171.1億美元
預測年份 [2024] 181.6億美元
預測年份 [2030] 260.5億美元
複合年成長率（%） 6.19%

市場動態：快速發展的冠狀動脈繞道手術移植市場的關鍵市場洞察

供應和需求的動態相互作用正在改變冠狀動脈繞道手術手術市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 冠狀動脈疾病盛行率增加
    • 醫療保健支出不斷增加，心臟專科醫療中心數量不斷增加
    • CABG手術優惠報銷政策
  • 市場限制因素
    • 對冠狀動脈繞道手術併發症和風險的擔憂
  • 市場機會
    • 機器人輔助手術等微創CABG技術的發展
    • 手術技術和影像技術的進步
  • 市場挑戰
    • 預防冠狀動脈疾病的替代技術的可用性

波特五力：駕馭冠狀動脈繞道手術移植物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解冠狀動脈繞道手術移植市場的外部影響

外部宏觀環境因素在塑造冠狀動脈繞道手術移植物市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解冠狀動脈繞道手術手術市場的競爭格局

冠狀動脈繞道手術物市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣冠狀動脈繞道手術旁路移植物市場供應商的績效評估

FPNV 定位矩陣是評估冠狀動脈繞道手術移植物市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了冠狀動脈繞道手術移植市場的成功之路

冠狀動脈繞道手術移植物市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 冠狀動脈疾病盛行率增加
      • 醫療保健成本不斷上升，心臟專科中心數量不斷增加
      • CABG手術優惠報銷政策
    • 抑制因素
      • 對 CABG 手術相關併發症和風險的擔憂
    • 機會
      • 機器人輔助手術等微創CABG技術的發展
      • 手術和影像技術的進步
    • 任務
      • 預防冠狀動脈疾病的替代技術的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章冠狀動脈繞道手術移植市場：依方法分類

  • 微創直接冠狀動脈繞道術
  • 關閉泵浦
  • 在幫浦上

第7章冠狀動脈繞道手術繞道移植物市場分步實施

  • 雙冠狀動脈繞道手術
  • 4 次冠狀動脈繞道手術
  • 單次冠狀動脈繞道手術
  • 三重冠狀動脈繞道手術

第8章冠狀動脈繞道手術移植物市場：依產品

  • 胃網膜動脈
  • 乳內動脈移植物
  • 橈動脈
  • 大隱靜脈移植物

第9章美洲冠狀動脈繞道手術移植物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太冠狀動脈繞道手術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的冠狀動脈繞道手術手術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences
  • enVVeno Medical Corporation
  • Genesee Biomedical Inc.
  • Getinge AB
  • KARL STORZ SE & Co. KG
  • Medtronic PLC
  • Peters Surgical
  • Scanlan International, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Transonic Systems Inc.
  • Vascular Graft Solutions Ltd.
Product Code: MRR-2A0283E2559F

The Coronary Artery Bypass Grafts Market was valued at USD 17.11 billion in 2023, expected to reach USD 18.16 billion in 2024, and is projected to grow at a CAGR of 6.19%, to USD 26.05 billion by 2030.

The coronary artery bypass grafts (CABG) market involves surgical procedures used to improve blood flow to the heart by redirecting blood around clogged or diseased arteries. The necessity of CABG arises from its critical role in treating coronary artery disease (CAD), a leading cause of mortality globally. Its application is primarily in hospitals and cardiac centers, where complex procedures are performed to improve patient outcomes. End-use scope is broad, addressing acute coronary symptoms in both emergency situations and elective surgeries. Key growth factors in the CABG market include the increasing prevalence of CAD due to aging populations and lifestyle-related risk factors, advancements in surgical techniques, and innovations in graft materials like synthetic and tissue-engineered options. The growing demand for minimally invasive procedures represents a potential opportunity, as it can reduce recovery times and improve patient experiences. Strategic recommendations include investing in R&D for developing novel graft materials and techniques, expanding into emerging markets, and forming partnerships with healthcare providers for better outreach. However, the market faces limitations such as the high cost of procedures, regulatory challenges, and the availability of alternative treatments like angioplasty and stenting that might affect the growth trajectory. Addressing these challenges requires a focus on cost-reduction strategies and improved patient education to highlight the benefits of CABG. Areas ripe for innovation include the development of more durable and biocompatible graft materials, as well as advancements in robotic-assisted surgeries. Additionally, big data and AI can be leveraged to enhance patient outcomes by tailoring treatments and predicting complications. The market remains competitive, characterized by both established players and new entrants focusing on technological breakthroughs. To succeed, businesses must maintain a keen focus on technological advancements, cost-efficiency, and strategic collaborations to navigate the evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 17.11 billion
Estimated Year [2024] USD 18.16 billion
Forecast Year [2030] USD 26.05 billion
CAGR (%) 6.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coronary Artery Bypass Grafts Market

The Coronary Artery Bypass Grafts Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of coronary artery diseases
    • Rising healthcare expenditure and growing number of cardiac specialty centers
    • Favorable reimbursement policies for CABG surgery
  • Market Restraints
    • Concerns associated with complications and risk of CABG surgery
  • Market Opportunities
    • Development of minimally invasive CABG techniques such as robotic-assisted surgery
    • Advancements in surgical techniques and imaging technologies
  • Market Challenges
    • Availability of alternate technologies for prevention of coronary artery diseases

Porter's Five Forces: A Strategic Tool for Navigating the Coronary Artery Bypass Grafts Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coronary Artery Bypass Grafts Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coronary Artery Bypass Grafts Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coronary Artery Bypass Grafts Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coronary Artery Bypass Grafts Market

A detailed market share analysis in the Coronary Artery Bypass Grafts Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coronary Artery Bypass Grafts Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coronary Artery Bypass Grafts Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coronary Artery Bypass Grafts Market

A strategic analysis of the Coronary Artery Bypass Grafts Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronary Artery Bypass Grafts Market, highlighting leading vendors and their innovative profiles. These include AtriCure, Inc., Boston Scientific Corporation, Edwards Lifesciences, enVVeno Medical Corporation, Genesee Biomedical Inc., Getinge AB, KARL STORZ SE & Co. KG, Medtronic PLC, Peters Surgical, Scanlan International, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Transonic Systems Inc., and Vascular Graft Solutions Ltd..

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Bypass Grafts Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across Minimally Invasive Direct CABG, Off-Pump, and On-Pump.
  • Based on Procedure, market is studied across Double CABG Surgery, Quadruple CABG Surgery, Single CABG Surgery, and Triple CABG Surgery.
  • Based on Product, market is studied across Gastroepiploic Artery, Internal Thoracic Artery Grafts, Radial Artery, and Saphenous Vein Grafts.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of coronary artery diseases
      • 5.1.1.2. Rising healthcare expenditure and growing number of cardiac specialty centers
      • 5.1.1.3. Favorable reimbursement policies for CABG surgery
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with complications and risk of CABG surgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of minimally invasive CABG techniques such as robotic-assisted surgery
      • 5.1.3.2. Advancements in surgical techniques and imaging technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternate technologies for prevention of coronary artery diseases
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Coronary Artery Bypass Grafts Market, by Method

  • 6.1. Introduction
  • 6.2. Minimally Invasive Direct CABG
  • 6.3. Off-Pump
  • 6.4. On-Pump

7. Coronary Artery Bypass Grafts Market, by Procedure

  • 7.1. Introduction
  • 7.2. Double CABG Surgery
  • 7.3. Quadruple CABG Surgery
  • 7.4. Single CABG Surgery
  • 7.5. Triple CABG Surgery

8. Coronary Artery Bypass Grafts Market, by Product

  • 8.1. Introduction
  • 8.2. Gastroepiploic Artery
  • 8.3. Internal Thoracic Artery Grafts
  • 8.4. Radial Artery
  • 8.5. Saphenous Vein Grafts

9. Americas Coronary Artery Bypass Grafts Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Coronary Artery Bypass Grafts Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Coronary Artery Bypass Grafts Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AtriCure, Inc.
  • 2. Boston Scientific Corporation
  • 3. Edwards Lifesciences
  • 4. enVVeno Medical Corporation
  • 5. Genesee Biomedical Inc.
  • 6. Getinge AB
  • 7. KARL STORZ SE & Co. KG
  • 8. Medtronic PLC
  • 9. Peters Surgical
  • 10. Scanlan International, Inc.
  • 11. Stryker Corporation
  • 12. Teleflex Incorporated
  • 13. Terumo Corporation
  • 14. Transonic Systems Inc.
  • 15. Vascular Graft Solutions Ltd.

LIST OF FIGURES

  • FIGURE 1. CORONARY ARTERY BYPASS GRAFTS MARKET RESEARCH PROCESS
  • FIGURE 2. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY BYPASS GRAFTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CORONARY ARTERY BYPASS GRAFTS MARKET DYNAMICS
  • TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE DIRECT CABG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF-PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ON-PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY DOUBLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY QUADRUPLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY TRIPLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GASTROEPIPLOIC ARTERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY INTERNAL THORACIC ARTERY GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY RADIAL ARTERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SAPHENOUS VEIN GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2023